A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization
Related Experiment Video
Updated: Aug 8, 2026
Chromosome Preparation From Cultured Cells
Published on: January 28, 2014
I-Ming Chen1, Margaret Whalen, Arthur Bankhurst
1Department of Pathology, University of New Mexico School of Medicine, 900 Camino de Salud NE, Albuquerque, NM 87131-5636, USA.
Insights
A novel interleukin-2 dependent cell line, IMC-1, was developed from aggressive natural killer (NK) cell leukemia. This IMC-1 cell line exhibits functional NK cytotoxicity and aids research into NK cell biology and leukemia.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- Aggressive natural killer (NK) cell leukemia is a rare and aggressive hematologic malignancy.
- Establishing well-characterized cell lines is crucial for understanding disease mechanisms and developing therapies.
Observation:
- A new human interleukin-2 dependent leukemic cell line, IMC-1, was derived from a patient with aggressive NK cell leukemia.
- The IMC-1 cell line initially expressed NK cell surface antigens (CD56, CD2, CD11a, CD38, HLA-DR), with loss of CD16 and CD8 over time.
- Cytogenetic analysis revealed complex chromosomal abnormalities, including structural alterations in chromosome 8.
Findings:
- The IMC-1 cell line demonstrates functional NK cell cytotoxicity, lysing target cells independently of MHC and antibodies.
- Its cytotoxic efficiency is comparable or superior to freshly isolated NK cells.
- The cell line maintains complex chromosomal aberrations throughout prolonged culture.
Implications:
- The IMC-1 cell line provides a valuable model for studying NK cell biology and function.
- It can facilitate research into the role of chromosomal aberrations in leukemic transformation.
- This resource will aid in the development of targeted therapies for NK cell leukemia.
Abstract:
A new human IL-2 dependent leukemic cell line with a natural killer (NK) cell phenotype, IMC-1, was established from an adult patient with aggressive NK cell leukemia. The IMC-1 cell line expresses the CD56, CD2, CD11a, CD38 and HLA-DR cell surface antigens, whereas the CD16 and CD8 antigens expressed on the primary leukemic blasts from which the cell line was derived were lost after 7 and 28 weeks of culture, respectively. The IMC-1 cell line displays functional NK cytotoxicity and lyses target cells in a non-MHC restricted, antibody-independent manner with equal or superior efficiency to freshly isolated NK cells. Cytogenetic analysis at presentation and after 55 weeks in culture revealed complex structural and numerical abnormalities, defined by classic G-banding and by spectral karyotyping (SKY). Three apparently intact copies of chromosome 8 occurred in the diagnostic bone marrow specimen; the cell line also contains three copies of chromosome 8 but each was structurally altered. The development and detailed characterization of this new NK leukemic cell line will facilitate biologic and functional studies of NK cells and chromosomal aberrations potentially important in leukemic transformation.
